The analysis that suggests that there is an increased risk for those with FH vs. those non-FHers with equivalent serum lipid levels is probably seriously flawed. The reason is that the FHers in any study are a special, high risk CVD population and not representative of the 90% of FHers that everybody agrees have never been identified. The FH research community dismisses the idea that the "unidentified 90%" are different only because it is "too difficult to do a population study". Translated, this means "we don't know, it's too hard, so we will pretend we know, even though we don't". Real science can detect gravity waves in 40 years, but medical research can't do a population study of FH.